• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进行性骨化性纤维发育不良患者异位骨化的自然病史。一项对44例患者的研究。

The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients.

作者信息

Cohen R B, Hahn G V, Tabas J A, Peeper J, Levitz C L, Sando A, Sando N, Zasloff M, Kaplan F S

机构信息

Department of Orthopaedic Surgery, Hospital of the University of Pennsylvania, Philadelphia 19104.

出版信息

J Bone Joint Surg Am. 1993 Feb;75(2):215-9. doi: 10.2106/00004623-199302000-00008.

DOI:10.2106/00004623-199302000-00008
PMID:8423182
Abstract

Forty-four patients who had fibrodysplasia ossificans progressiva responded by mail to a questionnaire regarding the age at the onset of heterotopic ossification at fifteen commonly involved anatomical sites. The average age of the patients when they responded to the questionnaire was twenty-seven years (range, three to sixty-nine years). The average age at the onset of ossification was five years (range, birth to twenty-five years). The most common sites of early heterotopic ossification were the neck, spine, and shoulder girdle. Thirty-five (80 per cent) of the patients had had some restrictive heterotopic ossification by the age of seven years. By the age of fifteen years, forty-two (more than 95 per cent) of the patients had severely restricted mobility of the upper limbs. In these patients, heterotopic ossification proceeded in a direction that was axial to appendicular, cranial to caudad, and proximal to distal; this pattern appeared typical for fibrodysplasia ossificans progressiva.

摘要

44例进行性骨化性纤维发育不良患者通过邮件回复了一份关于15个常见受累解剖部位异位骨化发病年龄的问卷。患者回复问卷时的平均年龄为27岁(范围为3至69岁)。骨化开始的平均年龄为5岁(范围为出生至25岁)。早期异位骨化最常见的部位是颈部、脊柱和肩胛带。35例(80%)患者在7岁时就出现了一些限制性异位骨化。到15岁时,42例(超过95%)患者上肢活动严重受限。在这些患者中,异位骨化的发展方向是从躯干到四肢、从头部到尾部、从近端到远端;这种模式在进行性骨化性纤维发育不良中似乎是典型的。

相似文献

1
The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients.进行性骨化性纤维发育不良患者异位骨化的自然病史。一项对44例患者的研究。
J Bone Joint Surg Am. 1993 Feb;75(2):215-9. doi: 10.2106/00004623-199302000-00008.
2
Pseudomalignant heterotopic ossification.假性恶性异位骨化
Clin Orthop Relat Res. 1998 Jan(346):134-40.
3
Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva.成骨不全性纤维发育不良患者的早期死亡率和心肺衰竭。
J Bone Joint Surg Am. 2010 Mar;92(3):686-91. doi: 10.2106/JBJS.I.00705.
4
Hematopoietic stem-cell contribution to ectopic skeletogenesis.造血干细胞对异位骨骼生成的贡献。
J Bone Joint Surg Am. 2007 Feb;89(2):347-57. doi: 10.2106/JBJS.F.00472.
5
The Natural History of Flare-Ups in Fibrodysplasia Ossificans Progressiva (FOP): A Comprehensive Global Assessment.进行性骨化性纤维发育不良(FOP)发作的自然史:一项全面的全球评估。
J Bone Miner Res. 2016 Mar;31(3):650-6. doi: 10.1002/jbmr.2728. Epub 2015 Nov 14.
6
Early diagnosis of fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良的早期诊断。
Pediatrics. 2008 May;121(5):e1295-300. doi: 10.1542/peds.2007-1980.
7
Age- and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良患者初始异位骨化的年龄和关节特异性风险。
Clin Orthop Relat Res. 1994 Apr(301):243-8.
8
Fibrodysplasia ossificans progressiva: a current review of imaging findings.进行性骨化性纤维发育不良:影像学表现的当前综述
Skeletal Radiol. 2018 Aug;47(8):1043-1050. doi: 10.1007/s00256-018-2889-5. Epub 2018 Feb 14.
9
Severe restriction in jaw movement after routine injection of local anesthetic in patients who have fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良患者在常规注射局部麻醉剂后出现严重的下颌运动受限。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Jan;81(1):21-5. doi: 10.1016/s1079-2104(96)80141-7.
10
Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良患者的近端胫骨骨软骨瘤
J Bone Joint Surg Am. 2008 Feb;90(2):366-74. doi: 10.2106/JBJS.G.00774.

引用本文的文献

1
A cutaneous nodule revealing Münchmeyer's disease.一个显示明希迈尔病的皮肤结节。
Oxf Med Case Reports. 2025 May 28;2025(5):omaf045. doi: 10.1093/omcr/omaf045. eCollection 2025 May.
2
The Use of Bone Biomarkers, Imaging Tools, and Genetic Tests in the Diagnosis of Rare Bone Disorders.骨生物标志物、成像工具和基因检测在罕见骨病诊断中的应用
Calcif Tissue Int. 2025 Jan 22;116(1):32. doi: 10.1007/s00223-024-01323-z.
3
Is partial excision of the radial head safe and effective in all-arthroscopic treatment of terrible triad fractures?
在全关节镜治疗复杂肘关节恐怖三联征骨折中,桡骨头部分切除术是否安全有效?
Clin Shoulder Elb. 2024 Dec;27(4):454-463. doi: 10.5397/cise.2024.00703. Epub 2024 Nov 5.
4
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial.成纤维细胞性骨化发育不良成人患者flare-ups 的特征及 garetosmab 的影响:LUMINA-1 试验的一项随机、双盲、安慰剂对照的事后分析。
J Bone Miner Res. 2024 Sep 26;39(10):1486-1492. doi: 10.1093/jbmr/zjae140.
5
Research trends and hotspots of myositis ossificans: a bibliometric analysis from 1993 to 2022.骨化性肌炎的研究趋势与热点:1993年至2022年的文献计量分析
EFORT Open Rev. 2024 Jul 1;9(7):589-599. doi: 10.1530/EOR-23-0207.
6
Development of AAV-Mediated Gene Therapy Approaches to Treat Skeletal Diseases.腺相关病毒(AAV)介导的基因治疗方法治疗骨骼疾病的研究进展。
Hum Gene Ther. 2024 May;35(9-10):317-328. doi: 10.1089/hum.2024.022. Epub 2024 Apr 8.
7
Fibrodysplasia Ossificans Progressiva Mimics Generalized Dystonia Disorder: A Case Report.进行性骨化性纤维发育不良酷似全身性肌张力障碍疾病:一例报告
Cureus. 2023 Dec 19;15(12):e50769. doi: 10.7759/cureus.50769. eCollection 2023 Dec.
8
How Activin A Became a Therapeutic Target in Fibrodysplasia Ossificans Progressiva.激活素 A 如何成为进行性骨化性纤维发育不良的治疗靶点。
Biomolecules. 2024 Jan 12;14(1):101. doi: 10.3390/biom14010101.
9
Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic Frontiers.探索进行性骨化性纤维发育不良的复杂领域:从现有范式到治疗前沿。
Genes (Basel). 2023 Nov 30;14(12):2162. doi: 10.3390/genes14122162.
10
Reduced GS Domain Serine/Threonine Requirements of Fibrodysplasia Ossificans Progressiva Mutant Type I BMP Receptor ACVR1 in the Zebrafish.成纤维细胞生长因子受体 1 型突变型骨化性纤维发育不良 BMP 受体在斑马鱼中 GS 结构域丝氨酸/苏氨酸需求减少。
J Bone Miner Res. 2023 Sep;38(9):1364-1385. doi: 10.1002/jbmr.4869. Epub 2023 Jul 17.